U.S. Life Sciences Stock News

Customers Bancorp (NYSE:CUBI) has launched a new $100 million share repurchase program authorized by its Board of Directors. The buyback gives the bank a flexible tool to manage capital while signaling confidence in its financial position. The authorization comes as Customers Bancorp continues to focus on supporting clients and long term growth plans. Customers Bancorp, trading at $71.67, has seen its share price move around recently, with a 7 day return of 6.6% decline and a 30 day return...

NiSource (NYSE:NI) has secured a long term electricity supply contract with Amazon subsidiary ADS for its data centers. The agreement covers utility scale power needs that are expected to support ADS facilities over multiple years. The deal is described by NiSource as a transformational step in its infrastructure investment and growth plans. NiSource runs regulated utility operations, and this contract ties that core business directly to the ongoing build out of data center capacity. As...

DocuSign (NasdaqGS:DOCU) has launched new AI powered eSignature features as part of its Intelligent Agreement Management platform. The new tools focus on contract specific AI support to simplify legal documentation and address workflow friction for enterprises. The update introduces enhanced eSignature capabilities designed to improve how organizations manage and execute agreements. For you as an investor, this move sits squarely in the core line of business for DocuSign: digital agreement...

Align Technology is partnering with the University of Bern on Switzerland's first comprehensive Swiss Oral Health Study. The project uses Align's iTero Lumina digital scanners and mobile dental vans to collect real time oral health data across the country. The collaboration focuses on preventive care insights and broader public health impact beyond Align's core orthodontic products. For investors watching NasdaqGS:ALGN, this research tie up sits alongside a share price of $183.86 and mixed...

Callaway Golf (NYSE:CALY) has refocused on its core golf equipment business by selling a majority stake in Topgolf and divesting Jack Wolfskin. The company reports a reduction of $1b in debt and a move to a net cash position following these transactions. Callaway Golf has also launched a $200m share repurchase program, signaling a shift in its approach to capital returns. For investors tracking NYSE:CALY, the story is now centered squarely on golf equipment, not adjacent leisure or apparel...

Inspire Medical Systems (INSP) has wrapped up FY 2025 with Q4 revenue of US$269.1 million and basic EPS of US$4.70, alongside net income of US$136.1 million. Its trailing 12 month figures show revenue of US$912.0 million and basic EPS of US$4.95. The company has seen revenue move from US$802.8 million to US$912.0 million on a trailing 12 month basis, with basic EPS shifting from US$1.80 to US$4.95 over the same period. This sets the stage for investors to focus on how much of that growth is...

Cisco Systems (CSCO) has just posted Q2 2026 results with revenue of US$15.3b and basic EPS of US$0.80, supported by net income of US$3.2b, giving investors a fresh read on how its core business is performing. The company has seen quarterly revenue move from US$14.0b and EPS of US$0.61 in Q2 2025 to US$15.3b and EPS of US$0.80 in Q2 2026. Trailing twelve month net profit margin sits at 18.8% versus 17% a year earlier, indicating a period where profitability has become more efficient even as...

Alexandria Real Estate Equities (NYSE:ARE) is facing an investor lawsuit alleging misrepresentation of leasing spreads, tenant pipeline, and occupancy at a Long Island City property. The complaint cites potential securities law violations and focuses on whether key property metrics were accurately communicated to shareholders. At the same time, the company is pursuing multiple refinancing actions, including an upsized tender for existing notes and a new $750 million senior note issue. For...

HubSpot (HUBS) has wrapped up FY 2025 with Q4 revenue of US$846.7 million and basic EPS of US$1.04, alongside trailing 12 month revenue of about US$3.1 billion and basic EPS of US$0.88. This gives investors a clear read on the current earnings run rate. Over recent periods, the company has seen quarterly revenue move from US$703.2 million in Q4 2024 to US$846.7 million in Q4 2025, while quarterly basic EPS shifted from US$0.10 to US$1.04. The story now hinges on how consistently HubSpot can...

Phillips Edison & Company, Inc. recently reported past fourth-quarter and full-year 2025 results showing higher revenue of US$187.86 million and net income of US$47.53 million for the quarter, and issued 2026 guidance targeting net income per share between US$0.74 and US$0.77. An interesting aspect of this update is that management’s 2026 outlook includes Same-Center NOI growth of 3.8%, aligned with its stated long-term 3% to 4% range, suggesting confidence in the underlying performance of...

Green Plains has begun Carbon Capture and Sequestration operations, targeting the low carbon fuel market. The company is starting to benefit from related tax credits tied to these CCS activities. Management is also working on asset sales and debt restructuring to reshape the balance sheet. For investors watching NasdaqGS:GPRE, these moves come with the stock at $13.92 and a mixed performance record. The shares are up 10.0% over the past week, 24.2% over the past month, and 35.4% year to...

Anterix (ATEX) has just put out its Q3 2026 scorecard, with the latest reported quarter in the data set showing revenue of US$1.6 million and basic EPS of US$2.86, alongside trailing 12 month EPS of US$5.13 on net income of US$95.6 million that includes a one off gain of US$141.8 million. Over the past few reported periods, revenue has stayed in a tight band between roughly US$1.4 million and US$1.6 million per quarter, while basic EPS has moved from losses in early 2025 to positive readings...

If you are wondering whether Hilton Grand Vacations is attractively priced right now, the key question is how its current share price lines up with its underlying fundamentals. The stock closed at US$45.32 most recently, with returns of a 2.0% decline over 7 days, a 5.7% decline over 30 days, a 0.4% decline year to date, a 7.1% gain over 1 year, a 5.1% decline over 3 years and a 22.3% gain over 5 years. This gives you a mixed picture of shorter term pressure and longer term...

Ashland (NYSE:ASH) received US EPA approval for its Agrimer Eco-Coat polymer seed coating. The eco-focused technology is now cleared for commercial use in global agricultural markets. The approval marks an expansion of Ashland's presence in crop care solutions. Ashland, known for specialty materials and chemical solutions, is adding more weight to its agricultural offerings with Agrimer Eco-Coat now cleared for broader use. For investors watching the mix of chemistry and sustainability in...

Smurfit Westrock FY 2025 earnings snapshot Smurfit Westrock (SW) has wrapped up FY 2025 with fourth quarter revenue of US$7.6b, basic EPS of US$0.19 and net income of US$97m. This is setting the tone for how the full year is being read by the market. The company has seen revenue move from US$7.5b in Q4 FY 2024 to US$7.6b in Q4 FY 2025, while quarterly EPS shifted from US$0.28 to US$0.19 over the same period, against trailing twelve month EPS of US$1.34 and net income of US$699m on revenue of...

ITT (NYSE:ITT) is moving forward with a pending acquisition of SPX FLOW that would significantly expand its industrial capabilities. During the deal process, potential hidden liabilities at SPX FLOW have been disclosed, raising questions about future obligations ITT may assume. These developments arrive as ITT shares trade at $199.11, following multi year gains that include a 35.8% return over the past year and 173.4% over five years. For you as an investor, the combination of a large...

Watts Water Technologies (WTS) has wrapped up FY 2025 with fourth quarter revenue of US$625.1 million and basic EPS of US$2.51, backed by trailing twelve month revenue of about US$2.4 billion and EPS of US$10.17. The company has seen revenue move from US$540.4 million and EPS of US$2.02 in Q4 2024 to US$625.1 million and EPS of US$2.51 in Q4 2025. This sets up a story in which higher net profit margins and earnings growth sit at the center of how investors read this latest update. See our...

Alamo Group (NYSE:ALG) is experiencing ongoing revenue and earnings declines tied to persistently high production costs. These elevated costs are compressing the company’s gross margin and weighing on overall financial performance. The trend has continued over multiple years, raising fresh questions about operational efficiency and long term profitability. Alamo Group, trading at around $209.2, is coming under closer scrutiny as its revenue and earnings move lower while production costs...

Ridgepost Capital (RPC) has just posted its FY 2025 numbers with Q3 total revenue at US$75.9 million and basic EPS of US$0.02, while trailing twelve month revenue stands at US$301.3 million and EPS at US$0.14, as investors weigh these against a mixed earnings backdrop affected by a one off US$33.1 million loss. Over recent quarters, revenue has moved from US$71.1 million in Q2 2024 to US$75.9 million in Q3 2025, while quarterly EPS shifted from US$0.06 to US$0.02. This sets the stage for a...

If you are wondering whether Vital Farms at around US$27.71 is priced attractively today, the key question is whether the current share price lines up with the underlying business value. The stock has been choppy, with a 5.8% gain over the last 7 days, a 9.4% decline over 30 days, a 7.1% decline year to date, a 21.8% decline over 1 year, but an 82.4% return over 3 years and a 2.7% decline over 5 years. Recent news coverage has focused on Vital Farms' position in the pasture raised egg and...

Conduent (CNDT) has just posted its FY 2025 third quarter numbers, with revenue of US$767 million and a net income loss of US$48 million, translating to basic EPS of a US$0.31 loss. Over recent quarters the company has seen revenue move from US$828 million and EPS of US$1.09 in Q2 2024 to US$751 million and EPS of a US$0.33 loss in Q1 2025, before landing at US$767 million and EPS of a US$0.31 loss in Q3 2025. Trailing twelve month figures now sit at US$3.1 billion of revenue and an EPS loss...

West Pharmaceutical Services (WST) just posted its FY 2025 third quarter scorecard, with revenue of US$804.6 million and basic EPS of US$1.94 setting the tone for the latest update. The company has seen revenue move from US$702.1 million in Q2 2024 to US$804.6 million in Q3 2025, while basic EPS has ranged from US$1.52 in Q2 2024 to US$1.94 in the latest quarter. This gives investors a clearer view of how the top line and per share earnings have tracked through the last six reported periods...

TransUnion (TRU) just posted its latest FY 2025 numbers with Q3 revenue of US$1.2b, basic EPS of US$0.50 and net income excluding extra items of US$96.6m, set against trailing 12 month revenue of US$4.4b and EPS of US$2.16. These figures reflect an 87.5% year over year earnings jump and a move in net margin from 5.5% to 9.5%. The company has seen quarterly revenue range from US$1.0b in Q4 2024 to US$1.2b in Q3 2025. Over the same period, quarterly EPS moved from US$0.34 to US$0.76 and then...

Agios Pharmaceuticals (AGIO) just posted its FY 2025 third quarter numbers, with revenue of US$12.9 million, basic EPS of a US$1.78 loss, and a net income loss of US$103.4 million. The trailing twelve month figures show revenue of US$44.8 million and a net loss of US$401.3 million. The company’s quarterly revenue moved from US$8.6 million in Q2 2024 to US$12.9 million in Q3 2025, while basic EPS shifted from US$16.65 in Q3 2024, driven by a one-off gain, to consistent losses across recent...